Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Lifetime Links RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title claims abstract description 50 235000003969 glutathione Nutrition 0.000 title claims abstract description 19 229960003180 glutathione Drugs 0.000 title claims abstract description 19 239000000203 mixture Substances 0.000 title claims abstract description 16 150000001875 compounds Chemical class 0.000 title claims abstract 5 VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims abstract description 8 GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 claims abstract description 7 230000002829 reductive effect Effects 0.000 claims abstract description 7 HBQJTBXZMPSVBP-UHFFFAOYSA-N Cyanidine Natural products OC1=CC(=C2/Oc3cc(O)cc(O)c3C=C2O)C=CC1=O HBQJTBXZMPSVBP-UHFFFAOYSA-N 0.000 claims abstract description 6 241001465754 Metazoa Species 0.000 claims abstract description 6 FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 claims abstract description 5 LFNJHSYJNCVQTR-VGWMRTNUSA-N (2s)-2-[[[(1s)-1-carboxy-4-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-4-oxobutyl]-ethylamino]sulfanyloxysulfanyl-ethylamino]-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)N(CC)SOSN(CC)[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O LFNJHSYJNCVQTR-VGWMRTNUSA-N 0.000 claims abstract 3 MTOYAHNULTYFRA-XUXIUFHCSA-N (2s)-2-[[[(1s)-1-carboxy-4-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-4-oxobutyl]-methylamino]sulfanyloxysulfanyl-methylamino]-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)N(C)SOSN(C)[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O MTOYAHNULTYFRA-XUXIUFHCSA-N 0.000 claims abstract 3 150000003254 radicals Chemical class 0.000 claims description 22 238000011282 treatment Methods 0.000 claims description 21 102000004190 Enzymes Human genes 0.000 claims description 14 108090000790 Enzymes Proteins 0.000 claims description 14 230000001225 therapeutic effect Effects 0.000 claims description 13 XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 5 230000003078 antioxidant effect Effects 0.000 claims description 5 GVJHHUAWPYXKBD-UHFFFAOYSA-N ()--Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4 230000002255 enzymatic effect Effects 0.000 claims description 4 239000002516 radical scavenger Substances 0.000 claims description 4 BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 3 229910052711 selenium Inorganic materials 0.000 claims description 3 239000011669 selenium Substances 0.000 claims description 3 FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 2 239000004201 L-cysteine Substances 0.000 claims description 2 235000013878 L-cysteine Nutrition 0.000 claims description 2 FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2 229930003427 Vitamin E Natural products 0.000 claims description 2 OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 2 FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 2 235000013734 beta-carotene Nutrition 0.000 claims description 2 239000011648 beta-carotene Substances 0.000 claims description 2 TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 2 229960002747 betacarotene Drugs 0.000 claims description 2 WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2 230000036542 oxidative stress Effects 0.000 claims description 2 235000019155 vitamin A Nutrition 0.000 claims description 2 239000011719 vitamin A Substances 0.000 claims description 2 235000019165 vitamin E Nutrition 0.000 claims description 2 229940046009 vitamin E Drugs 0.000 claims description 2 239000011709 vitamin E Substances 0.000 claims description 2 229940045997 vitamin a Drugs 0.000 claims description 2 OENHQHLEOONYIE-JLTXGRSLSA-N -Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 2 DRUFOBPADLRUEF-WDSKDSINSA-N OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)NSOP(O)(O)=O Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)NSOP(O)(O)=O DRUFOBPADLRUEF-WDSKDSINSA-N 0.000 claims 2 238000005502 peroxidation Methods 0.000 claims 1 239000000126 substance Substances 0.000 abstract description 12 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1 NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 1 108010024636 Glutathione Proteins 0.000 description 28 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 22 -1 thiol derivative of glutathione Chemical class 0.000 description 20 208000035475 disorder Diseases 0.000 description 13 235000010208 anthocyanin Nutrition 0.000 description 12 239000004410 anthocyanin Substances 0.000 description 12 229930002877 anthocyanin Natural products 0.000 description 12 230000015572 biosynthetic process Effects 0.000 description 9 238000002560 therapeutic procedure Methods 0.000 description 9 RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8 150000004636 anthocyanins Chemical class 0.000 description 8 238000006243 chemical reaction Methods 0.000 description 8 201000010099 disease Diseases 0.000 description 7 208000006454 hepatitis Diseases 0.000 description 7 210000004027 cell Anatomy 0.000 description 6 150000003573 thiols Chemical class 0.000 description 6 238000005755 formation reaction Methods 0.000 description 5 231100000283 hepatitis Toxicity 0.000 description 5 238000011321 prophylaxis Methods 0.000 description 5 108010053070 Glutathione Disulfide Proteins 0.000 description 4 230000019522 cellular metabolic process Effects 0.000 description 4 230000006378 damage Effects 0.000 description 4 230000006870 function Effects 0.000 description 4 KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 4 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4 150000002926 oxygen Chemical class 0.000 description 4 LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3 WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3 OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3 206010028813 Nausea Diseases 0.000 description 3 244000172533 Viola sororia Species 0.000 description 3 230000007812 deficiency Effects 0.000 description 3 229940079593 drug Drugs 0.000 description 3 239000003814 drug Substances 0.000 description 3 230000035987 intoxication Effects 0.000 description 3 231100000566 intoxication Toxicity 0.000 description 3 210000004379 membrane Anatomy 0.000 description 3 239000012528 membrane Substances 0.000 description 3 230000008693 nausea Effects 0.000 description 3 229910052760 oxygen Inorganic materials 0.000 description 3 239000001301 oxygen Substances 0.000 description 3 230000005855 radiation Effects 0.000 description 3 210000001519 tissue Anatomy 0.000 description 3 231100000331 toxic Toxicity 0.000 description 3 230000002588 toxic effect Effects 0.000 description 3 YCKXUKSFLUVEKE-WDSKDSINSA-N (2S)-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxo-2-[(4-oxo-1,3,2,4lambda5-dioxathiaphosphetan-4-yl)oxyamino]pentanoic acid Chemical compound S1OP(ON[C@H](C(=O)O)CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)(O1)=O YCKXUKSFLUVEKE-WDSKDSINSA-N 0.000 description 2 ZYECOAILUNWEAL-NUDFZHEQSA-N (4z)-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]hydrazinylidene]-n-(3-nitrophenyl)-3-oxonaphthalene-2-carboxamide Chemical compound COC1=CC=C(C(=O)NC=2C=CC=CC=2)C=C1N\N=C(C1=CC=CC=C1C=1)/C(=O)C=1C(=O)NC1=CC=CC([N+]([O-])=O)=C1 ZYECOAILUNWEAL-NUDFZHEQSA-N 0.000 description 2 AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2 JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 description 2 IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2 206010002383 Angina Pectoris Diseases 0.000 description 2 206010003210 Arteriosclerosis Diseases 0.000 description 2 108020004414 DNA Proteins 0.000 description 2 DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2 206010019708 Hepatic steatosis Diseases 0.000 description 2 MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2 206010020751 Hypersensitivity Diseases 0.000 description 2 206010061218 Inflammation Diseases 0.000 description 2 206010027476 Metastases Diseases 0.000 description 2 206010028980 Neoplasm Diseases 0.000 description 2 206010063493 Premature ageing Diseases 0.000 description 2 208000032038 Premature aging Diseases 0.000 description 2 NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2 230000001154 acute effect Effects 0.000 description 2 230000007815 allergy Effects 0.000 description 2 QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2 210000000601 blood cell Anatomy 0.000 description 2 201000011510 cancer Diseases 0.000 description 2 230000015556 catabolic process Effects 0.000 description 2 208000019425 cirrhosis of liver Diseases 0.000 description 2 230000000295 complement effect Effects 0.000 description 2 210000002808 connective tissue Anatomy 0.000 description 2 235000007242 delphinidin Nutrition 0.000 description 2 JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 2 238000001784 detoxification Methods 0.000 description 2 206010012601 diabetes mellitus Diseases 0.000 description 2 235000013399 edible fruits Nutrition 0.000 description 2 230000002068 genetic effect Effects 0.000 description 2 YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2 229940045883 glutathione disulfide Drugs 0.000 description 2 JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2 208000015181 infectious disease Diseases 0.000 description 2 230000004054 inflammatory process Effects 0.000 description 2 230000003859 lipid peroxidation Effects 0.000 description 2 210000002540 macrophage Anatomy 0.000 description 2 235000009584 malvidin Nutrition 0.000 description 2 230000004060 metabolic process Effects 0.000 description 2 238000000034 method Methods 0.000 description 2 208000010125 myocardial infarction Diseases 0.000 description 2 230000001590 oxidative effect Effects 0.000 description 2 HGBOYTHUEUWSSQ-UHFFFAOYSA-N pentanal Chemical compound CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 2 230000002265 prevention Effects 0.000 description 2 230000008569 process Effects 0.000 description 2 235000018102 proteins Nutrition 0.000 description 2 102000004169 proteins and genes Human genes 0.000 description 2 108090000623 proteins and genes Proteins 0.000 description 2 150000004053 quinones Chemical class 0.000 description 2 230000001105 regulatory effect Effects 0.000 description 2 238000006467 substitution reaction Methods 0.000 description 2 239000002676 xenobiotic agent Substances 0.000 description 2 KPDBZQCSCRQTMT-ONGXEEELSA-N (2s)-5-[[(2r)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-2-(2,5-dihydroxyanilino)-5-oxopentanoic acid Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(O)=O)NC1=CC(O)=CC=C1O KPDBZQCSCRQTMT-ONGXEEELSA-N 0.000 description 1 SATICYYAWWYRAM-VNKDHWASSA-N (E,E)-hepta-2,4-dienal Chemical compound CC\C=C\C=C\C=O SATICYYAWWYRAM-VNKDHWASSA-N 0.000 description 1 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1 ZSBBXCYFJOZGFX-UHFFFAOYSA-N 2-phenylchromen-2-ol Chemical compound O1C2=CC=CC=C2C=CC1(O)C1=CC=CC=C1 ZSBBXCYFJOZGFX-UHFFFAOYSA-N 0.000 description 1 ZPDKTVJZFVWAOC-UHFFFAOYSA-N 4-hydroxy-1,3,2,4lambda5-dioxathiaphosphetane 4-oxide Chemical compound S1OP(O1)(O)=O ZPDKTVJZFVWAOC-UHFFFAOYSA-N 0.000 description 1 PYWFGGNTBVBZAT-GQCTYLIASA-N 4-hydroxy-2-octenal Chemical compound CCCCC(O)\C=C\C=O PYWFGGNTBVBZAT-GQCTYLIASA-N 0.000 description 1 JYTUBIHWMKQZRB-ONEGZZNKSA-N 4-hydroxyhexenal Chemical compound CCC(O)\C=C\C=O JYTUBIHWMKQZRB-ONEGZZNKSA-N 0.000 description 1 TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1 241001136792 Alle Species 0.000 description 1 206010002091 Anaesthesia Diseases 0.000 description 1 206010059245 Angiopathy Diseases 0.000 description 1 PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1 ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1 206010006895 Cachexia Diseases 0.000 description 1 208000031229 Cardiomyopathies Diseases 0.000 description 1 102000016938 Catalase Human genes 0.000 description 1 108010053835 Catalase Proteins 0.000 description 1 208000002177 Cataract Diseases 0.000 description 1 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1 208000017667 Chronic Disease Diseases 0.000 description 1 206010008909 Chronic Hepatitis Diseases 0.000 description 1 206010010356 Congenital anomaly Diseases 0.000 description 1 ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1 MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1 241000196324 Embryophyta Species 0.000 description 1 208000004930 Fatty Liver Diseases 0.000 description 1 206010016654 Fibrosis Diseases 0.000 description 1 WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1 102000006587 Glutathione peroxidase Human genes 0.000 description 1 108700016172 Glutathione peroxidases Proteins 0.000 description 1 102000005720 Glutathione transferase Human genes 0.000 description 1 108010070675 Glutathione transferase Proteins 0.000 description 1 239000004471 Glycine Substances 0.000 description 1 241000282412 Homo Species 0.000 description 1 WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1 206010025327 Lymphopenia Diseases 0.000 description 1 206010064912 Malignant transformation Diseases 0.000 description 1 WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1 206010028851 Necrosis Diseases 0.000 description 1 208000012902 Nervous system disease Diseases 0.000 description 1 208000025966 Neurological disease Diseases 0.000 description 1 CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1 108700020962 Peroxidase Proteins 0.000 description 1 102000003992 Peroxidases Human genes 0.000 description 1 241000606701 Rickettsia Species 0.000 description 1 101710172711 Structural protein Proteins 0.000 description 1 OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1 102000019197 Superoxide Dismutase Human genes 0.000 description 1 108010012715 Superoxide dismutase Proteins 0.000 description 1 210000001744 T-lymphocyte Anatomy 0.000 description 1 208000025865 Ulcer Diseases 0.000 description 1 244000154870 Viola adunca Species 0.000 description 1 235000005811 Viola adunca Nutrition 0.000 description 1 235000013487 Viola odorata Nutrition 0.000 description 1 235000002254 Viola papilionacea Nutrition 0.000 description 1 241000700605 Viruses Species 0.000 description 1 206010052428 Wound Diseases 0.000 description 1 208000027418 Wounds and injury Diseases 0.000 description 1 238000000862 absorption spectrum Methods 0.000 description 1 230000009471 action Effects 0.000 description 1 238000009098 adjuvant therapy Methods 0.000 description 1 150000001299 aldehydes Chemical class 0.000 description 1 230000000172 allergic effect Effects 0.000 description 1 230000003281 allosteric effect Effects 0.000 description 1 235000001014 amino acid Nutrition 0.000 description 1 150000001413 amino acids Chemical class 0.000 description 1 230000037005 anaesthesia Effects 0.000 description 1 208000007502 anemia Diseases 0.000 description 1 229930014669 anthocyanidin Natural products 0.000 description 1 235000008758 anthocyanidins Nutrition 0.000 description 1 208000011775 arteriosclerosis disease Diseases 0.000 description 1 208000010668 atopic eczema Diseases 0.000 description 1 210000003719 b-lymphocyte Anatomy 0.000 description 1 230000001580 bacterial effect Effects 0.000 description 1 230000008901 benefit Effects 0.000 description 1 230000001851 biosynthetic effect Effects 0.000 description 1 230000000711 cancerogenic effect Effects 0.000 description 1 231100000315 carcinogenic Toxicity 0.000 description 1 230000003197 catalytic effect Effects 0.000 description 1 210000003169 central nervous system Anatomy 0.000 description 1 238000002512 chemotherapy Methods 0.000 description 1 230000007882 cirrhosis Effects 0.000 description 1 239000005515 coenzyme Substances 0.000 description 1 230000021615 conjugation Effects 0.000 description 1 210000004087 cornea Anatomy 0.000 description 1 208000029078 coronary artery disease Diseases 0.000 description 1 235000007336 cyanidin Nutrition 0.000 description 1 XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1 235000018417 cysteine Nutrition 0.000 description 1 239000000824 cytostatic agent Substances 0.000 description 1 230000001085 cytostatic effect Effects 0.000 description 1 ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1 230000007123 defense Effects 0.000 description 1 230000002950 deficient Effects 0.000 description 1 230000007850 degeneration Effects 0.000 description 1 230000003412 degenerative effect Effects 0.000 description 1 238000004925 denaturation Methods 0.000 description 1 230000036425 denaturation Effects 0.000 description 1 230000001419 dependent effect Effects 0.000 description 1 230000001066 destructive effect Effects 0.000 description 1 230000006866 deterioration Effects 0.000 description 1 230000004069 differentiation Effects 0.000 description 1 238000006073 displacement reaction Methods 0.000 description 1 230000000694 effects Effects 0.000 description 1 230000003511 endothelial effect Effects 0.000 description 1 208000010706 fatty liver disease Diseases 0.000 description 1 NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1 238000002695 general anesthesia Methods 0.000 description 1 235000013922 glutamic acid Nutrition 0.000 description 1 239000004220 glutamic acid Substances 0.000 description 1 229930182470 glycoside Natural products 0.000 description 1 150000002338 glycosides Chemical class 0.000 description 1 210000003714 granulocyte Anatomy 0.000 description 1 229910001385 heavy metal Inorganic materials 0.000 description 1 210000002443 helper t lymphocyte Anatomy 0.000 description 1 125000000623 heterocyclic group Chemical group 0.000 description 1 PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1 210000005260 human cell Anatomy 0.000 description 1 230000007062 hydrolysis Effects 0.000 description 1 238000006460 hydrolysis reaction Methods 0.000 description 1 TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 1 230000033444 hydroxylation Effects 0.000 description 1 238000005805 hydroxylation reaction Methods 0.000 description 1 238000002639 hyperbaric oxygen therapy Methods 0.000 description 1 230000001900 immune effect Effects 0.000 description 1 208000021267 infertility disease Diseases 0.000 description 1 230000002757 inflammatory effect Effects 0.000 description 1 239000003112 inhibitor Substances 0.000 description 1 230000003834 intracellular effect Effects 0.000 description 1 230000005865 ionizing radiation Effects 0.000 description 1 201000002364 leukopenia Diseases 0.000 description 1 231100001022 leukopenia Toxicity 0.000 description 1 150000002632 lipids Chemical class 0.000 description 1 210000004185 liver Anatomy 0.000 description 1 208000019423 liver disease Diseases 0.000 description 1 231100001023 lymphopenia Toxicity 0.000 description 1 230000036212 malign transformation Effects 0.000 description 1 230000003211 malignant effect Effects 0.000 description 1 229940118019 malondialdehyde Drugs 0.000 description 1 210000004962 mammalian cell Anatomy 0.000 description 1 238000002483 medication Methods 0.000 description 1 210000001616 monocyte Anatomy 0.000 description 1 210000004400 mucous membrane Anatomy 0.000 description 1 230000035772 mutation Effects 0.000 description 1 210000000822 natural killer cell Anatomy 0.000 description 1 230000017074 necrotic cell death Effects 0.000 description 1 230000000269 nucleophilic effect Effects 0.000 description 1 238000011275 oncology therapy Methods 0.000 description 1 210000000056 organ Anatomy 0.000 description 1 210000003463 organelle Anatomy 0.000 description 1 YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1 238000002640 oxygen therapy Methods 0.000 description 1 230000008506 pathogenesis Effects 0.000 description 1 230000001717 pathogenic effect Effects 0.000 description 1 230000001991 pathophysiological effect Effects 0.000 description 1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1 235000006251 pelargonidin Nutrition 0.000 description 1 XVFMGWDSJLBXDZ-UHFFFAOYSA-O pelargonidin Chemical compound C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 XVFMGWDSJLBXDZ-UHFFFAOYSA-O 0.000 description 1 229930015721 peonidin Natural products 0.000 description 1 235000006404 peonidin Nutrition 0.000 description 1 XFDQJKDGGOEYPI-UHFFFAOYSA-O peonidin Chemical compound C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 XFDQJKDGGOEYPI-UHFFFAOYSA-O 0.000 description 1 230000002093 peripheral effect Effects 0.000 description 1 210000001428 peripheral nervous system Anatomy 0.000 description 1 230000035699 permeability Effects 0.000 description 1 230000003617 peroxidasic effect Effects 0.000 description 1 229940097156 peroxyl Drugs 0.000 description 1 229930015717 petunidin Natural products 0.000 description 1 235000006384 petunidin Nutrition 0.000 description 1 AFOLOMGWVXKIQL-UHFFFAOYSA-O petunidin Chemical compound OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 AFOLOMGWVXKIQL-UHFFFAOYSA-O 0.000 description 1 230000000144 pharmacologic effect Effects 0.000 description 1 230000000258 photobiological effect Effects 0.000 description 1 210000004180 plasmocyte Anatomy 0.000 description 1 239000002243 precursor Substances 0.000 description 1 230000002028 premature Effects 0.000 description 1 230000035755 proliferation Effects 0.000 description 1 238000006862 quantum yield reaction Methods 0.000 description 1 238000007348 radical reaction Methods 0.000 description 1 238000003608 radiolysis reaction Methods 0.000 description 1 238000001959 radiotherapy Methods 0.000 description 1 230000009467 reduction Effects 0.000 description 1 230000008929 regeneration Effects 0.000 description 1 238000011069 regeneration method Methods 0.000 description 1 230000008439 repair process Effects 0.000 description 1 210000001525 retina Anatomy 0.000 description 1 208000013363 skeletal muscle disease Diseases 0.000 description 1 231100000240 steatosis hepatitis Toxicity 0.000 description 1 238000009102 step therapy Methods 0.000 description 1 230000035882 stress Effects 0.000 description 1 230000002459 sustained effect Effects 0.000 description 1 208000011580 syndromic disease Diseases 0.000 description 1 238000003786 synthesis reaction Methods 0.000 description 1 230000000451 tissue damage Effects 0.000 description 1 231100000827 tissue damage Toxicity 0.000 description 1 229940042585 tocopherol acetate Drugs 0.000 description 1 230000002110 toxicologic effect Effects 0.000 description 1 231100000027 toxicology Toxicity 0.000 description 1 239000011573 trace mineral Substances 0.000 description 1 235000013619 trace mineral Nutrition 0.000 description 1 231100000397 ulcer Toxicity 0.000 description 1 235000021122 unsaturated fatty acids Nutrition 0.000 description 1 150000004670 unsaturated fatty acids Chemical class 0.000 description 1 230000002792 vascular Effects 0.000 description 1 210000004127 vitreous body Anatomy 0.000 description 1 XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1 230000003313 weakening effect Effects 0.000 description 1 Classifications AHUMAN NECESSITIES A61MEDICAL OR VETERINARY SCIENCE
Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death
These observations suggest that in terms of stress tolerance, the production of exopolysaccharides may serve an on/off function rather than a gradient of tolerance, and that the increased production of exopolysaccharides due to pH stress may have another role
Dull, tired-looking skin
